Approval · Notice of Compliance 25302 · 2021
TOMUDEX: Notice of Compliance 25302
Issued February 26, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25302
- Date
- February 26, 2021
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- The addition of an alternate drug substance manufacturer and testing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TOMUDEX | Not yet assigned | — |
Medicinal ingredients
- RALTITREXED DISODIUM 2 MG per VIAL